Report on Cardiovascular Health and Diseases in China 2025: An Updated Summary

The "Report on Cardiovascular Health and Diseases in China 2025", guided by the National Health Commission and compiled under the auspices of the National Center for Cardiovascular Diseases, systematically integrates multi-dimensional data on cardiovascular diseases (CVD) trends, the evolution of risk factors, advances in diagnosis and treatment, rehabilitation management, medical device innovation, and health economics evaluations in China, providing a scientific basis for policy formulation, resource allocation, and intervention prioritization. According to the data, CVD remains the leading cause of death among urban and rural residents in China, accounting for 48.98% of rural deaths and 47.35% of urban deaths in 2021, approximately 2 in every 5 deaths were attributable to CVD. Although the age-standardized mortality rate has declined, the absolute number of CVD cases and deaths continues to rise due to accelerated population aging and the high prevalence of risk factors. In 2024, the crude incidence rate of CVD among Chinese residents aged 18 years and above was 639.46 per 100,000 population, with rates higher in males than in females. The mortality rate in rural areas has consistently remained higher than in urban areas. The Healthy China Action Plan (2019-2030) sets a target to reduce the mortality rate of cardiovascular and cerebrovascular diseases to below 190.7 per 100,000 population by 2030. To achieve this goal, the report calls for a refined monitoring system to continuously track key health indicators, including tobacco use, dietary patterns, physical activity, sleep quality, body mass index, blood pressure, blood lipids, blood glucose, and environmental exposures. This effort aims to facilitate the transition from a "treatment-centered" to a "health-centered" approach.